ISIS has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Isis Pharmaceuticals's quarterly cash and cash equivalents declined from Sep. 2013 ($256.4 Mil) to Dec. 2013 ($160.0 Mil) but then increased from Dec. 2013 ($160.0 Mil) to Mar. 2014 ($161.8 Mil).
Isis Pharmaceuticals's annual cash and cash equivalents increased from Dec. 2011 ($65.5 Mil) to Dec. 2012 ($124.5 Mil) and increased from Dec. 2012 ($124.5 Mil) to Dec. 2013 ($160.0 Mil).
Cash and cash equivalents on banks book.
* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.
Isis Pharmaceuticals Annual Data
Isis Pharmaceuticals Quarterly Data